Journal Mobile Options
Table of Contents
Vol. 32, No. 3, 2009
Issue release date: March 2009
Neuroepidemiology 2009;32:171–175

Prevalence of Possible Idiopathic Normal-Pressure Hydrocephalus in Japan: The Osaki-Tajiri Project

Tanaka N. · Yamaguchi S. · Ishikawa H. · Ishii H. · Meguro K.
aDepartment of Geriatric Behavioral Neurology, Tohoku University Graduate School of Medicine, Sendai, bKawasaki Kokoro Hospital, Kawasaki, and cThe Osaki-Tajiri SKIP Center, Osaki, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Several studies have reported that the prevalence of idiopathic normal-pressure hydrocephalus (iNPH) was between 0 and 5%. However, the precise prevalence in a community-based elderly population remains unclear. We investigated the prevalence of possible iNPH retrospectively using an age- and gender-stratified random sample database. Methods: Five hundred and sixty-seven participants were randomly selected from among the 1,654 members of the population aged 65 years and older in Tajiri, Japan, and 497 underwent MRI. We classified participants as having possible iNPH if they had: (1) ventricular enlargement, as shown by an Evans index of ≥0.3, with closing sulci at the high convexity with dilation of the sylvian fissure on MRI, (2) at least one of the iNPH clinical triad (gait disturbance, urinary incontinence and cognitive impairment), and (3) no identifiable potential secondary cause of hydrocephalus. Results: We found 7 participants who met the criteria mentioned above. Cognitive impairments were the most common symptoms (n = 6) followed by gait disturbances (n = 3); however, urinary incontinence was not observed. No full clinical triad was present in the patients and only 3 participants had 2 of the triad. Conclusions: We considered the prevalence of possible iNPH in elderly adults to be 1.4% (95% confidence interval = 0.6–2.9%).

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Evans WA: An encephalographic ratio for estimating ventricular and cerebral atrophy. Arch Neurol Psychiatry 1942;73:9–12.
  2. Hebb AO, Cusimano MD: Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome. Neurosurgery 2001;49:1166–1184.
  3. Jellinger K: Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 1976;76:83–102.
  4. Fisher CM: Hydrocephalus as a cause of disturbances of gait in the elderly. Neurology 1982;32:1358–1363.
  5. Larson EB, Reifler BV, Featherstone HJ, English DR: Dementia in elderly outpatients: a prospective study. Ann Intern Med 1984;100:417–423.
  6. Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD: Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology 1992;42:54–59.
  7. Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, Oertel WH: Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinson’s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 1995;52:1017–1022.
  8. Bech-Azeddine R, Waldemar G, Knudsen GM, Hogh P, Bruhn P, Wildschiodtz G, Gjerris F, Paulson OB, Juhler M: Idiopathic normal-pressure hydrocephalus: evaluation and findings in a multidisciplinary memory clinic. Eur J Neurol 2001;8:601–611.
  9. Vale FA, Miranda SJ: Clinical and demographic features of patients with dementia attended in a tertiary outpatient clinic. Arq Neuropsiquiatr 2002;60:548–552.
  10. Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA: Incidence and causes of nondegenerative nonvascular dementia: a population-based study. Arch Neurol 2006;63:218–221.
  11. Marmarou A, Young HF, Aygok GA: Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities. Neurosurg Focus 2007;22:E1.
  12. Brean A, Eide PK: Prevalence of probable idiopathic normal pressure hydrocephalus in a Norwegian population. Acta Neurol Scand 2008;118:48–53.
  13. Hiraoka K, Meguro K, Mori E: Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community. Neurol Med Chir (Tokyo) 2008;48:197–199.
  14. Krauss JK, Halve B: Normal pressure hydrocephalus: survey on contemporary diagnostic algorithms and therapeutic decision-making in clinical practice. Acta Neurochir 2004;146:379–388.
  15. Meguro K, Ishii H, Yamaguchi S, Ishizaki J, Shimada M, Sato M, Hashimoto R, Shimada Y, Meguro M, Yamadori A, Sekita Y: Prevalence of dementia and dementing diseases in Japan: the Tajiri project. Arch Neurol 2002;59:1109–1114.
  16. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
  17. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM: Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:S4–S16.
  18. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  19. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM: The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:S17–S28.
  20. Armstrong GD: The intraclass correlation as a measure of interrater reliability of subjective judgments. Nurs Res 1981;30:314–315, 320A.
  21. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T: CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. Am J Neuroradiol 1998;19:1277–1284.
  22. Otoyama W, Niina R, Homma A, Sanada J, Takahashi M, Kamimura N, Mimori Y, Katayama S, Urakami K, Yamada M, Takeuchi H, Mizuno K, Nishizawa Y, Ono Y: Inter-rater reliability of the Japanese version of Clinical Dementia Rating (CDR). Jap J Geriatr Psychiatry 2000;11:521–527.
  23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944.
  24. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
  25. Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, Takeuchi T, Kazui H, Koyama H: Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 2008;48(suppl):S1–S23.
  26. Ojemann RG, Fisher CM, Adams RD, Sweet WH, New PF: Further experience with the syndrome of ‘normal’ pressure hydrocephalus. J Neurosurg 1969;31:279–294.
  27. Savolainen S, Paljarvi L, Vapalahti M: Prevalence of Alzheimer’s disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study. Acta Neurochir 1999;141:849– 853.
  28. Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, Hermans J: Dutch normal-pressure hydrocephalus study: the role of cerebrovascular disease. J Neurosurg 1999;90:221–226.
  29. Golomb J, Wisoff J, Miller DC, Boksay I, Kluger A, Weiner H, Salton J, Graves W: Alzheimer’s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry 2000;68:778–781.
  30. Spagnoli D, Innocenti L, Bello L, Pluderi M, Bacigaluppi S, Tomei G, Gaini SM: Impact of cerebrovascular disease on the surgical treatment of idiopathic normal pressure hydrocephalus. Neurosurgery 2006;59:545–552.
  31. Krauss JK, Regel JP, Vach W, Droste DW, Borremans JJ, Mergner T: Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke 1996;27:24–29.
  32. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D: Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2003;2:506–511.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50